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Enhancers are genetic elements that regulate spatio-
temporal gene expression. Enhancer function re-
quires transcription factor (TF) binding and corre-
lates with histone modifications. However, the
extent to which TF binding and histonemodifications
functionally define active enhancers remains unclear.
Here, we combine chromatin immunoprecipitation
with a massively parallel reporter assay (ChIP-
STARR-seq) to identify functional enhancers in
human embryonic stem cells (ESCs) genome-wide
in a quantitative unbiased manner. Although active
enhancers associate with TFs, only a minority of re-
gions marked by NANOG, OCT4, H3K27ac, and
H3K4me1 function as enhancers, with activity mark-
edly changing under naive versus primed culture
conditions. We identify an enhancer set associated
with functions extending to non-ESC-specific pro-
cesses. Moreover, although transposable elements
associate with putative enhancers, only some exhibit
activity. Similarly, within super-enhancers, large
tracts are non-functional, with activity restricted
to small sub-domains. This catalog of validated
enhancers provides a valuable resource for further
functional dissection of the regulatory genome.
INTRODUCTION
Human embryonic stem cells (ESCs) are a genetically tractable
developmental model system with potential for stem-cell-based
therapeutics. Understanding how ESC pluripotency is regulated
by transcription factors (TFs) is central to achieving this promise.
Gene expression is modulated by cis-regulatory elements, such
as enhancers (Banerji et al., 1981), which can stimulate target
gene expression in a position and orientation-independent
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This is an open access article under the CC BY license (http://creativeFurlong, 2012). ESCs direct a specific gene expression program
using a network of TFs including OCT4, SOX2, and NANOG.
Compared to mouse ESCs, human ESCs are more developmen-
tally advanced with characteristics of post-implantation em-
bryos. Recently, so-called naive ESCs with pre-implantation
embryo characteristics have been derived from established
ESCs either by transient transgene expression (Buecker et al.,
2010; Hanna et al., 2010; Takashima et al., 2014) or by altering
culture conditions (Gafni et al., 2013; Theunissen et al., 2014).
Naive ESCs differ from primed ESCs in several ways, including
increased clonogenicity, different growth factor requirements,
distinct energy metabolism, and altered morphology (Sperber
et al., 2015), but how naive and primed ESCs differ in enhancer
usage is currently unclear.
The past decade of genomics research has focused on
cataloguing cis-regulatory elements within the non-coding
genome (ENCODE Project Consortium, 2012). Technological
advances have allowed genome-wide occupancy by TFs
to be measured by chromatin immunoprecipitation (ChIP)
followed by sequencing (ChIP-seq). Putative enhancer locations
have been obtained by mapping histone modifications (e.g.,
H3K27ac, H3K4me1) (Rada-Iglesias et al., 2011) and by
measuring chromatin accessibility (Buenrostro et al., 2013).
However, not all predicted enhancers could be validated
functionally. To assay enhancer activity, plasmid-based cell
transfections can be used. Recent advances have enabled thou-
sands of sequences to be tested simultaneously (Kwasnieski
et al., 2012; Melnikov et al., 2012; Patwardhan et al., 2012).
For instance, with self-transcribing active regulatory region
sequencing (STARR-seq) compact, non-mammalian genomes
can be quantitatively screened for enhancer activity by cloning
randomly sheared DNA between a minimal-promoter-driven
GFP open reading frame and a downstream polyA sequence. If
an enhancer is active, this results in transcription of the enhancer
sequence (Arnold et al., 2013). Similar approaches have been
adapted to test chosen sequences with putative enhancer fea-
tures (Kwasnieski et al., 2014; Vanhille et al., 2015), predicted
TF binding sites (Verfaillie et al., 2016), features of quantitative
trait loci (Tewhey et al., 2016), or nucleosome-depleted se-
quences (Murtha et al., 2014).Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
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Figure 1. ChIP-STARR-Seq in Human Em-
bryonic Stem Cells
(A) Outline of the ChIP-STARR-seq approach
combining antibodies against TFs or histone
modifications (colored balls) with the STARR-seq
plasmid (Arnold et al., 2013).
(B) ChIP-STARR-seq for NANOG in H9. Scatter-
plots compare normalized read count (reads per
million) per peak between datasets, obtained from
ChIP-seq or DNA-seq of plasmid libraries pre- or
post-transfection/recovery from ESCs (n = 2); r,
Pearson correlation.
(C) Genomic distribution of peaks called for
ChIP-seq (outer chart) and corresponding
plasmid libraries (inner chart). TSSs, transcrip-
tion start sites.
(D) FACS plots of single DAPI-negative ESCs.
Left: untransfected cells; right: cells trans-
fected with a NANOG ChIP-STARR-seq plasmid
library.
(E) Scatterplot (like in B) comparing the NANOG
plasmid library and corresponding ChIP-
STARR-seq RNA. The dense cluster of points in
the lower left corresponds to library plasmids
that did not produce RNAs. RPM, reads per
million.
(F) Genome browser plot of SOX2 showing tracks
for ChIP-seq, DNA-seq of plasmid libraries pre-
and post-transfection, and from RNA-seq of GFP+
cells transfected with the indicated libraries. Bot-
tom: combination (maximum) of all STARR-seq
RNA-seq tracks and ratio of normalized RNA-seq/
plasmid reads.
(G) Genome browser shots of KLF15, LEFTY, and
HOXB cluster, illustrating a broad variety of en-
hancers profiled in this functional enhancer
catalog.Application of STARR-seq to explore mammalian genomes
is hindered by genome size which means enhancer sequences
would be infrequently sampled. This issue can be alleviated by
combining ChIP with STARR-seq (Vockley et al., 2016). Using
a similar approach (that we refer to as ‘‘ChIP-STARR-seq’’), we
generate a resource of genome-wide activity maps of func-
tional enhancers in ESCs. This identifies highly active en-
hancers with major changes in activity patterns between
primed and naive ESCs. Moreover, some transposable
element (TE) families are enriched at highly active enhancers.
Our data also identify the functional components within su-
per-enhancers (SEs) and uncover a previously unidentified
set of enhancers, including some associated with house-
keeping functions. This resource encompasses an extensive
collection of functional enhancer sequences in ESCs, providing
a knowledge base for systematic analysis of the transcriptional
circuitry underlying ESC maintenance and differentiation.
Enhancer data are available from the STAR Methods and from
a resource website (http://hesc-enhancers.computational-
epigenetics.org).RESULTS
ChIP-STARR-Seq: An Effective Strategy for Genome-
wide Identification of Functional Enhancers
To generate a catalog of genomic elements that regulate ESC
biology, we used a massively parallel reporter assay called
‘‘ChIP-STARR-seq.’’ InChIP-STARR-seq,DNA is co-immunopre-
cipitated and cloned en masse within the transcription unit of a
STARR-seq plasmid that is downstream of GFP driven by a mini-
mal promoter and upstream of a polyA sequence (Figure 1A) (Ar-
noldet al., 2013). The resultant libraries canbe tested for enhancer
activity by cell transfection. If a cloned sequence functions as an
enhancer, the transfected GFP-positive cells can be purified by
fluorescence-activated cell sorting (FACS). Since the assayed se-
quences lie upstream of the polyA signal, the transcribed mRNA
will contain the enhancer sequence. Therefore, both the identity
and activity of captured regions can be determined quantitatively
by sequencing mRNA (RNA-seq) from GFP-positive cells.
To investigate the functional potential of enhancers in ESCs,
we first focused on primed H9 ESCs (Figures S1A and S1B)Cell Stem Cell 23, 276–288, August 2, 2018 277
and performed ChIP for NANOG, OCT4, H3K4me1 and
H3K27ac. ChIP-qPCR and ChIP-seq were similar to previous re-
sults (Figures S1C and 1D). Although plasmid transfection can
elicit an immune response in some cell types (Muerdter et al.,
2018), the low expression of STING and CGAS in H1 (Muerdter
et al., 2018) and H9 (Figure S1E) suggests this does not apply
to ESCs. ChIP-STARR-seq libraries were generated (see the
STAR Methods). Sequencing precipitated DNA, plasmid li-
braries, and transcribed RNAs produced 2.73 109 reads in total.
Each plasmid library consisted of 8.4–30.8 3 106 unique plas-
mids, with a mean insert size of 221 bp (Table S1). Figure S2A
summarizes the sequenced samples analyzed in this study.
We first assessed whether the plasmid libraries achieved a
good representation of the binding events captured by ChIP-
seq (Data S1). A good correlation between ChIP-seq coverage
and the corresponding plasmid libraries was seen both pre-
and post-transfection (Figures 1B, 1C, S2B, and S2C). Next,
the ability of the plasmid libraries to drive GFP expression in
primed ESCs was tested. Library transfections produced up to
20% GFP-positive cells compared to <1% GFP-positive cells
obtained by transfection of the empty STARR-seq vector or
50% cherry-positive in control transfections with a constitu-
tively expressed mCherry plasmid (Figure 1D; data not shown).
Therefore, a considerable proportion of cells contained plasmids
with enhancer activity. 24 hr post-transfection, DNA was pre-
pared from unsorted cells and RNA from FACS-purified GFP-
positive cells was amplified for RNA-seq. DNA sequencing
confirmed high consistency between the original plasmid li-
braries and plasmids re-isolated post-transfection (Figures 1B
and S2C). Positive correlations were also observed between
read coverage from STARR-RNA-seq and the respective
plasmid libraries (Figures 1E and S2D) and between replicate
STARR-RNA-seq datasets, with an increase for expressed plas-
mids sampled in replicates (mean correlation r = 0.77 at read
count R 5). These results show that while abundant plasmids
can produce more RNA, some plasmids produce RNA in excess
of the plasmid count, indicating high enhancer activity. However,
many plasmids transfected into cells did not produce RNA indi-
cating that the ChIP-enriched DNA in these plasmids lacked
enhancer activity.
Visual inspection of selected genomic regions illustrates the
broad spectrum of enhancer activity measured by ChIP-
STARR-seq (Figures 1F and 1G). For instance, ChIP-seq for
NANOG indicates two strong binding sites up- and downstream
of SOX2 (Figure 1F), but only the downstream binding site
resulted in ChIP-STARR-seq RNA in excess of plasmid
abundance.
Activity Levels Define Classes of Enhancers Bound by
Distinct Transcription Factors
Using ChIP-STARR-seq, we assessed the functional capacity of
361,737 genomic regions in primed ESCs (Table S2). Enhancer
activity was defined as the ratio of RNA reads relative to plasmid
reads after normalization (RPP, reads per plasmid). Paired-end
sequencing enabled unequivocal assignment of RNA reads to
plasmids. The activity level of each region was recorded as the
activity generated by the most active plasmid (from any library)
within this region. The activities of 68 genomic regions covering
the full activity range were compared with luciferase-based as-278 Cell Stem Cell 23, 276–288, August 2, 2018says, and included regions covered in ChIP-seq and evaluated
as not active in the STARR-seq assay. DNAs from regions
of < 64 RPP had luciferase activities indistinguishable from
empty vector. In contrast, regions with increasingly high ChIP-
STARR-seq activity showed gradually higher luciferase activity
(Figure 2A). Using different minimal promoters did not affect
the activity calls of selected regions (Figure S3A). To assess
the relationship of activity classifications to gene expression,
each region was assigned to a putative target gene based on
genomic distance. ChIP-STARR-seq regions with enhancer ac-
tivity were associated with genes that showed significantly
higher gene expression values than genes associated with re-
gions lacking enhancer activity (Figures 2B and S3B). To simplify
further analysis and ease interpretation, we defined thresholds
for discriminating genuine enhancer activity from the activity of
the minimal promoter in the STARR-seq by examining mathe-
matical changepoints in the ranked curve of RPP values (Fig-
ure 2C). The greatest changepoint (q R 138) was taken as the
threshold to define active enhancers. Based on these thresh-
olds, ChIP-STARR-seq identified 32,353 active enhancers (Fig-
ure 2C; Data S1).
Applying this threshold to regions bound by NANOG, OCT4,
H3K4me1, H3K27ac, or combinations of these factors indicates
that only a minority of ChIP-seq peaks showed enhancer activity
(Figure 2D and S3C), with regions bound by OCT4 having the
highest proportion of high activity enhancers. To determine
whether activity predictions from the plasmid-based assay iden-
tified enhancers functional at the endogenous loci, ESCs with
deletions of regions exhibiting or lacking STARR-seq activity
were engineered using CRISPR-Cas9 (Figures 2E and S3D).
Changes in gene expression at each locus were observed only
for the target gene and only when an active element was deleted.
Removal of inactive regions was without effect.
The endogenous context of assessed regions was examined
by comparing our data to public reference datasets starting
with the H9 chromatin segmentation (Kundaje et al., 2015) (Fig-
ure 2F). Chromatin segments marked as enhancers, transcrip-
tion start sites (TSSs), sites flanking transcription and repeat se-
quences were most overrepresented in active regions. The
relative representation of TFs from 190 ChIP-seq datasets from
CODEX was next assessed by LOLA enrichment analysis (Sa´n-
chez-Castillo et al., 2015; Sheffield and Bock, 2016) (Figure 2G;
Table S3). High activity enhancers were preferentially associated
with pluripotency-related TFs (SOX2, SMAD3, OCT4, and
NANOG). Overlaps were also seen for regions bound in non-
ESCs by STAT5 and NCOR1. In contrast, no TFs were enriched
at inactive regions. Similar results were obtained by extending
the analysis to 690 ChIP-seq datasets for TFs from ENCODE
Project Consortium (2012) (Figure S3E). Enhancer activity was
strongest close to the binding peaks of enriched factors with ac-
tivity lost quickly with increasing distance from the peak center
(Figure 2H and S3F). These results suggest that binding of
distinct TFs in close proximity may contribute to robust enhancer
activity. How enhancer classes relate to chromatin state was
further examined by LOLA analysis of ENCODE chromatin seg-
mentations from H1 ESCs and various non-pluripotent cell types
(Figures S3G and S3H). This confirmed that active enhancers
were enriched in segments annotated as H1 enhancers and
promoters, while inactive regions occurred primarily in closed
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Figure 2. Activity Levels Define Functional Classes of Enhancers
(A) Luciferase activities of 68 genomic sequences in primed ESCs grouped by ChIP-STARR-seq activity. Boxes are interquartile range (IQR); line is median; and
whiskers are the 10th to the 90th percentile. *p < 0.05; **p < 0.01; ***p < 0.001; Mann-Whitney test; n = 2.
(B) Distribution of expression values (Takashima et al., 2014) of genes associated with enhancers grouped by activity level. Boxes are IQR; line is median;
whiskers extend to 1.53 the IQR; and dots are outliers. **p < 0.01; ***p < 0.001; unpaired t test.
(C) Plot showing enhancer activity (enrichment of ChIP-STARR-seqRNAover plasmids; log2) ranked from lowest to highest across all measured enhancers (union
of all peak calls). Enhancers were distinguished based on activity; dashed lines indicate thresholds (q).
(D) Distribution of active (RPPR 138) and inactive sequences (RPP < 138) in peaks called for the indicated factors.
(E) qRT-PCR analysis of wild-type (WT) and enhancer-deleted heterozygous (+/) or homozygous (/) ESC clones. Indicated mRNAs are normalized to TBP
(WT = 1), and the average results for the indicated deletions are plotted relative to wild-type; n = number of cell lines per genotype (see STARMethods for further
details). *p < 0.05; **p < 0.01; ***p < 0.001 (two-way ANOVA, Bonferroni post-test). Error bars represent SD.
(F) Relative enrichment of H9 chromatin segment overlaps (Kundaje et al., 2015) between regions with ChIP-STARR-seq activity and inactive regions (see C).
(G) Relative LOLA enrichment of TFs from CODEX (Sa´nchez-Castillo et al., 2015) in inactive regions and active enhancers. Odds ratios between observed
frequencies of enhancers overlapping binding sites for the eight most enriched TFs in the respective groups relative to the percentage in the entire region set are
shown, ranked by mean odds ratio. Each dot represents a TF ChIP-seq dataset. ChIP-seq datasets from non-ESCs are shown as crosses.
(H) Smooth line plots of the proportion of active plasmids (RPPR 138) around the peak center for the indicated ChIP-seq binding sites.
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A B C Figure 3. Sequence Determinants of
Enhancer Activity
(A) Receiver operating characteristic (ROC) curve
of the random forest classifier performance. AUC,
area under the curve.
(B) The top-40 sequence features used to distin-
guish active and inactive regions ordered by vari-
able importance. HOCOMOCO motif IDs were
shortened (Kulakovskiy et al., 2016).
(C) Line plots of the percentage of regions con-
taining one of the top-3 motifs from HOCOMOCO
as a function of enhancer activity. Each point is the
fraction of regions with at least log2(RPP+1) also
containing the respective motif.chromatin. Together, these results indicate that ChIP-STARR-
seq can distinguish ChIP-seq peaks on the basis of enhancer
activity and that enhancer activity reflects expression and regu-
latory function at the endogenous loci.
Sequence Determinants of Enhancer Activity
To address what distinguishes active enhancers from inactive
regions, we used a machine learning approach to train a classi-
fier to discriminate both types of regions based on sequence fea-
tures (conservation, GC content, dinucleotide frequencies) and
TF binding motif occurrence (see the STAR Methods). Mediocre
classifier performance was achieved (AUC = 0.72; Figure 3A).
The most informative features for enhancer activity were
sequence conservation, ESC-related TF binding motifs occur-
rence, and various dinucleotide frequencies (Figure 3B), in line
with recent observations from other MPRA data (Kreimer et al.,
2017). The top-3 enriched TFs were found in higher abundance
at regions with increasing RPP (Figure 3C). Our analysis
highlights sequence features influencing enhancer activity but
indicates that computational analysis with the simple features
assessed could not unequivocally predict activity.
Active ESC Enhancers Include an Extended Module
Containing Enhancers Associated with Housekeeping
Functions
High-throughput sequencing studies have attempted to predict
ESC enhancers on the basis of histone marks, TF binding, or
DNaseI hypersensitivity (Hawkins et al., 2011; Rada-Iglesias
et al., 2011; Xie et al., 2013). However, the overlap between en-
hancers predicted from these studies is limited (Figure S4A).
Comparing the combination of three previously described
enhancer maps with our dataset, 7,948 of the 32,353 active en-
hancers identified by ChIP-STARR-seq were among these pre-
dicted enhancers (n = 76,666; union of all datasets) (Table S2).
Several putative enhancers predicted by these previous studies
that were inactive by ChIP-STARR-seq were tested in luciferase
assays but none possessed enhancer activity in this assay (Fig-
ure S4B). Enrichment analysis using GREAT (McLean et al.,
2010) showed that the active ChIP-STARR-seq enhancer subset
overlapping with previously predicted enhancers had stronger
enrichment for gene ontology (GO) terms related to ESC biology
than terms identified from all predicted enhancers (Table S3).
This ‘‘core enhancer module’’ (Figure 4A) includes enhancers in
close proximity to ESC TFs (NANOG, OCT4) and signaling
pathway genes (TGF-b, FGF, WNT signaling). The remaining280 Cell Stem Cell 23, 276–288, August 2, 201824,405 enhancers with high ChIP-STARR-seq activity, that
were not predicted previously, had GO terms associated with
more generic processes; e.g., regulation of transcription, chro-
mosome organization, housekeeping processes, and cytoskel-
eton organization. We therefore refer to these enhancers as the
‘‘extended enhancer module.’’
A comparison of the ChIP-seq signal intensity for all peaks to
peaks associated with either the core or extended module indi-
cates that enhancers of the extended module generally had
slightly lower association with H3K4me1, NANOG, and OCT4
(Figure 4B). Reduced NANOG and OCT4 binding suggests that
extended enhancers rely less on ESC-specific TFs, which is sup-
ported by a machine learning classifier attempt to discriminate
enhancer modules based on sequence features (Figures S4D
and S4E). This analysis demonstrated that core enhancers could
be identified by CG dinucleotide frequency, GC content, and the
occurrence of OCT4 and NANOG binding motifs. Nonetheless,
the extended module sequences are bona fide enhancers, as
their activities are similar to core enhancers (Figure 4C). Similarly,
the expression of genes associated with the core and extended
enhancer modules was comparable, with both gene sets ex-
pressed significantly above average (p < 0.05) (Figures 4D and
S4C). Consistent with function in many cell types, expression
of genes associated with the extended enhancer module was
higher than core-module-associated genes in data from somatic
tissues obtained from the RNA-Seq Atlas (Krupp et al., 2012)
(Figure 4E) and GTEx Consortium (2013) (Figure S4F). To provide
context, we included orthogonal ‘‘housekeeping’’ (Eisenberg
and Levanon, 2013) and ‘‘tissue-specific’’ gene sets (Lachmann
et al., 2018) in this analysis. Enrichment analysis using Enrichr
(Chen et al., 2013) with data from ENCODE Project Consortium
(2012) or ChEA (Lachmann et al., 2010) showed that coremodule
enhancers were enriched near genes bound by NANOG, TCF3,
SOX2, and OCT4, whereas extended enhancer module en-
hancers showed preferential enrichment of broadly expressed
factors, such as TAF1, YY1, BRCA1, and ATF2 (Figure 4F; Table
S3). Core enhancers were often found in regions associated with
enhancer-like chromatin in H9 (Kundaje et al., 2015) (Figure 4G).
In contrast, 6% of extended module enhancers are annotated
as heterochromatic or bivalent in H9 chromatin, suggesting that
the activity of these enhancers may be suppressed by endoge-
nous chromatin. The majority of enhancers from either the core
or extended modules showed a similar distance distribution
around TSSs, although a subset of extended module enhancers
(n = 4,731) lie within 2 kb of TSSs (Figure 4H). GO terms
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Figure 4. Active Enhancers Include Core
and Extended ESC-Enhancer Modules
(A) The overlap between published putative
enhancers (Hawkins et al., 2011; Rada-Iglesias
et al., 2011; Xie et al., 2013) (light blue) and regions
assessed by ChIP-STARR-seq (white) or called
active (RPP R 138; blue). We refer to ChIP-
STARR-seq enhancers overlapping published
putative enhancers as the ‘‘coremodule’’ and non-
overlapping regions as the ‘‘extended module.’’
(B) Kernel density plots of the distribution of
enrichment values in ESCs for the indicated factor
for peaks associated with the core or extended
modules or for inactive regions.
(C) RPP values for all assessed genomic regions
compared to enhancers from the core or extended
modules. Boxes are IQR; line is median; and
whiskers extend to 1.53 the IQR.
(D) RNA-seq in H9 (Takashima et al., 2014) for all
genes compared to genes associated with either
core or extended enhancer modules. Boxes like in
(C). RPKM, reads per kilobase million. * p < 0.05;
*** p < 0.001 (t test).
(E) Gene expression in tissues from the RNA-seq
Atlas (Krupp et al., 2012) for all genes linked to the
core or extended modules. Housekeeping (Ei-
senberg and Levanon, 2013) and tissue-specific
genes (Lachmann et al., 2018) are also shown.
Tissue-specific genes are split into the one indi-
cated (same; x axis) or ‘‘other tissues.’’ As no tis-
sue-specific gene set was available for hypothal-
amus, whole-brain-specific genes were used.
Boxes like in D.
(F) Enrichment analysis (Enrichr) testing genes
associated with the core (top) and extended
(bottom) modules. Top-10 results for TF binding
sites from ENCODE and ChEA (left) and genes
downregulated (middle) or upregulated (right)
upon single-gene perturbations from GEO.
(G) Relative enrichment (log-odds ratio in ESCs
compared to all) of H9 chromatin segments
(Kundaje et al., 2015) in core and extendedmodule
enhancers.
(H) Kernel density plot of the distance to associ-
ated genes for core and extended module en-
hancers. Shortest distance from either enhancer
region boundary was recorded.associated with the TSS-proximal subset are enriched for terms
related to metabolic processes and housekeeping functions,
whereas terms associated with TSS-distal enhancers include
cell fate and differentiation annotations (Table S3). This indicates
that a subset of extended module enhancers may be linked to
housekeeping genes. ChIP-STARR-seq therefore identified by
function, previously unappreciated enhancer sequences charac-
terized by lower enrichment of enhancer-associated histone
modifications and pluripotency-related TFs but with comparable
enhancer activity.
Major Changes in Enhancer Activity upon Induction of
Naive Pluripotency
To augment the catalog of functional enhancers in ESCs and to
gauge the dynamics of enhancer activity we applied ChIP-
STARR-seq to a closely related cell type. Primed H9 ESCs
were converted to naive ESCs (Figures S5A–S5D). Characteriza-tion of established cultures agreed with prior studies (Barakat
et al., 2015; Gafni et al., 2013), as did ChIP-qPCR and ChIP-
seq for NANOG, OCT4, H3K4me1, and H3K27ac (Figures
S5E–S5I). ChIP-STARR-seq plasmid libraries generated from
naive ESCs (Figures 5A and S6) were transfected into naive
ESCs and for comparison, into primed ESCs. Transfections fol-
lowed by RNA-seq readout yielded measurements of enhancer
activity in naive ESCs comparable to those obtained previously
in primed ESCs, albeit at slightly lower reproducibility (mean cor-
relation r = 0.63 at read countR 5). Enhancer activity was cate-
gorized using the threshold applied previously (Table S2; Data
S1). 359,880 regions covered by plasmids in naive ESCs (Fig-
ure S6C) were analyzed, identifying 36,417 enhancers. Again,
only a fraction of ChIP-seq peaks displayed activity with peaks
marked by OCT4, H3K27ac and H3K4me1 showing the highest
proportion of activity (Figure S6D). LOLA enrichment analysis
of TFs from CODEX for the naive enhancer class (Figure 5B;Cell Stem Cell 23, 276–288, August 2, 2018 281
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Figure 5. Changes in Enhancer Activity
upon Induction of Naive Pluripotency
(A) Overview of primed to naive conversion and
ChIP-STARR-seq cross-over design.
(B) Relative enrichment of TFs from CODEX
(Sa´nchez-Castillo et al., 2015) in inactive, and
active enhancers in naive hESCs. Plots like in
Figure 2G.
(C) Table of relative changes in enhancer activity
between primed and naive ESCs.
(D) Enrichment analysis (Enrichr) to test genes near
enhancers active in both primed and naive ESCs
against GO assignments (left) or binding sites from
ENCODE and ChEA ChIP-seq (right).
(E) Scatterplot contrasting average changes in
enhancer activity with changes in associated
gene expression. Genes with strong concordant
changes in enhancer activity and gene expression
are shown using the thresholds: jmax(DRPP)jR 5,
jmean(DmRNA)jR 1.
(F) Visualization of enhancer activity in ChIP-
STARR-seq regions near selected genes (boxes in
E; TSS ± 40 kb) with differential expression in
primed and naive ESCs. Bars indicate enhancer
activity (RPP) in primed (blue) and naive (red)
ESCs. Grey dashed bars indicate activity
threshold for active enhancers. Active enhancers
are highlighted with asterisks. Gene name color
shows the state expressing the gene the highest.
(G) Scatterplot of scaled variable importance of
sequence features used to discriminate active and
inactive regions in primed and naive ESCs. In both
cases, a random forest classifier was trained.Table S3), identified a similar TF profile as in primed ESCs
(compare to Figure 2G). Sites bound by pluripotency-related
TFs (e.g., SOX2 and NANOG) were also strongly represented
at enhancers active in naive ESCs. Enrichment analysis of
ENCODE ChIP-seq datasets (Figure S6E) and chromatin seg-
mentations (Figures S6F and S6G) (Ernst et al., 2011; Kundaje
et al., 2015) confirmed overlap with ESC TF binding sites.
Having extensive genome-wide enhancer maps for both
pluripotent states allowed a global comparison of enhancer us-
age in both primed and naive ESCs (Figure 5C). Only 18% of en-
hancers active in primed ESCs maintained activity in naive ESCs
(Active/Active), whereas 82% became inactive (Active/Inac-
tive). Conversely, 9% of inactive regions in primed ESCs gained
activity (Inactive/Active). Despite these extensive changes, the
relative ranking of RPP values is stable, indicating that the high-
est and lowest activity score are comparable (Figure S6H). The
changes in activity are not explicable by altered affinity of TF
binding alone, as illustrated by discriminating peaks into strongly
and weakly bound regions (Figure S6I) and applying the same
analysis to ChIP-seq affinity values (Figure S6J). For instance,
only 36% of regions that maintained strong enhancer activity in
both states were also strongly bound in both states, whereas
15.3% of regions switched from strongly to weakly bound or
vice versa. Enrichment analysis of enhancers maintaining or
switching activity level (Figures 5D and S6K; Table S3) revealed
that enhancers with high activity in both cell states (Active/282 Cell Stem Cell 23, 276–288, August 2, 2018Active) were related to suppression of differentiation processes
and maintenance of stem cells, whereas genes near enhancers
that lost activity (Active/Inactive) were annotated with generic
expression-related terms. No significant GO terms were associ-
ated with enhancers that gained activity or regions that remained
inactive, though this may be due to lack of annotation in naive
ESCs. However, examining ChIP-seq data from ENCODE and
ChEA indicated that enhancers that were active only in naive
cells were enriched for transcriptional activators, such as
ATF2, TAF1, or BRCA1, that occur near target promoters.
Comparative analysis of core and extended module enhancers
(see Figure 4), showed that core enhancers were significantly
(p < 2.23 1016) more likely to be active in naive ESCs than either
extended module enhancers or enhancers inactive in primed
ESCs (Figure S6L).
To relate changes in enhancer activity to differences in the
expression of regulated genes, we plotted the average differ-
ence in enhancer RPP levels between naive and primed ESCs
against the expression of nearby genes (Figure 5E). We high-
lighted genes with at least one strong enhancer change. Detailed
examination of the ChIP-STARR-seq regions in the proximity
(%40 kb) of the TSS of these genes (Figure 5F; http://hesc-
enhancers.computational-epigenetics.org) confirmed increased
enhancer activities for several genes that were expressed higher
in naive ESCs (e.g., CD44, ANXA3). In contrast, several genes
were expressed more highly in primed ESCs and in each case
A C
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Figure 6. Distinct Transposable Elements
Are Associated with Enhancers of Differing
Activity in ESCs
(A) Enrichment ratios for the occurrence of TE
families (LTR, DNA, SINE, and LINE) in high activity
ChIP-STARR-seq enhancers (RPPR 138).
(B) Top-25 most enriched TE families in active
enhancers.
(C) Enrichment ratio versus activity level for
distinct TE families.
(D) Like in (C), but for the top-10 most enriched
families of TEs in (B).
(E) Comparison of the enrichment ratios in primed
and naive ESCs. Each repeat element is shown by
a dot with the size proportional to the number of
overlaps with ChIP-STARR-seq regions. Elements
with O/E R 3 in naive or primed or with strong
differences between both (O/E R 2 and Dlog2
(O/E)R 2) are labeled.
(F) Relative enrichment of selected TEs (from E) in
primed (blue) and naive (red) ESCs as a function of
enhancer activity level (RPP).
(G) Kernel density plots of coverage (ChIP-seq/
input) in ESCs for the indicated factor for all TEs
overrepresented (O/E > 2) in active enhancers.enhancers with increased activity in primed ESCs could be iden-
tified that may drive preferential expression in primed ESCs (e.g.,
BMP4/5, ID1/2). Notably, some genes showed concordant
changes in multiple adjacent enhancers that presumably jointly
drive expression changes (PRICKLE1, BMP4), whereas other
genes switched activity from one enhancer to another (PRUNE2,
CD44, and ZSCAN23). The catalog of functional enhancers pre-
sented here will help to decipher the complexity of enhancer/
target interactions directing gene expression.
Next, we trained a classifier to discriminate active from inac-
tive regions in naive ESCs and compared the results to those
we obtained previously (Figure 5G and S6M; Figure 3). We find
a consistent contribution of evolutionary conservation and GC/
CG dinucleotide frequencies to enhancer activity. Notably, the
relative importance of TF binding motifs shifts slightly between
naive and primed: e.g., ZIC3 is linked to naive ESCs (Warrier
et al., 2017), and SOX3 is linked to primed ESCs, in line with a
recent report on primed pluripotent mouse cells (Corsinotti
et al., 2017).Cell SThe Occurrence of Various
Transposable Elements Is
Associated with Enhancer Activity
As chromatin associated with repetitive
DNA was found in active enhancers (Fig-
ure 2F), we examined the link between re-
peats and enhancer activity more closely.
Large portions of mammalian genomes
are derived from TEs which are linked
to TF binding sites (Glinsky, 2015; Ku-
narso et al., 2010), but whether this
enrichment reflects enhancer activity
has not been determined genome-wide.
To assess ChIP-STARR-seq enhancers
for the occurrence of TE sequences, weused the RepeatMasker annotation (Kent et al., 2002). The num-
ber of TE-derived sequences in active and inactive regions was
compared to the number detected in all genomic regions (Fig-
ure 6; Table S4). LTR-containing TEs, such as LTR57, were en-
riched in primed ESCs enhancers (Figure 6A). However, not all
LTR-containing TEs were enriched at active enhancers. The
most enriched elements were satellite repeats and LTR family
members (Figure 6B). For TEs enriched for NANOG and OCT4
binding (e.g., LTR9B) (Kunarso et al., 2010) or TEs enriched
at candidate human-specific regulatory loci (e.g., LTR7) (Glinsky,
2015), the observed enrichment increased further with
increasing activity (Figures 6C and 6D). Indeed, LTR7, LTR9B
and HERVH-int show the strongest enrichment at the highest ac-
tivity enhancers. In contrast, other TE families previously linked
to human-specific TF binding sites (Glinsky, 2015), were either
not (L1HS) or only weakly (L1PA2) enriched at active enhancers.
Although many repeat families were found equally in primed and
naive ESCs (e.g., LTR7, (CATTC)n), other families showed less or
no enrichment in one of the two states (e.g., LTR81AB, LTR57)tem Cell 23, 276–288, August 2, 2018 283
Figure 7. ChIP-STARR-Seq Dissects Super-Enhancers into Functional Elements
(A) SEs were called from H3K27ac ChIP-seq data using ROSE (Whyte et al., 2013).
(B) Scatterplot of SE intensity (H3K27ac enrichment over input) with ChIP-STARR-seq activity. r, Pearson correlation; blue line indicates a generalized additive
model fit.
(C) SE overlapping FGFR1, with ChIP-seq tracks for the indicated factors in primed/naive ESCs. Top plot: SE locus; bottom plot: zooms into second intron. Shown
are the positions of regions assessed by ChIP-STARR-seq (gray) and active enhancers (blue) from this study and coordinates of luciferase constructs matching
selected enhancers (labeled A–H). Enhancer activities are concentrated at small regions.
(D) Luciferase assays of DNA sequences depicted in green in (C); n = 2. Error bars represent SD.
(E) Violin plots of the proportion of active plasmids (RPPR 138) for 1,369 SEs compared to normal enhancers (NE).
(F) Sketch of the active subspace (covered by plasmids with RPPR 138) of the entire SE space (all plasmids within SEs).
(G) Table of the percentage of ChIP-STARR-seq plasmids representing regions within SEs and NEs active in primed and naive ESCs (RPPR 138). Groups of
enhancers that were called SEs in both, in on, or in neither state are distinguished.(Figures 6E and 6F). In general, TEs that were overrepresented in
active enhancers showed increased binding of NANOG and
OCT4, but not H3K27ac or H3K4me1 (Figure 6G). These results
indicate that certain families of TEs are overrepresented at active
enhancers and that their enrichment correlates with enhancer
activity in a cell-state-dependent manner. However, not all TEs
of the same type are associated with active enhancers, nor do
all TEs enriched in pluripotency TF binding sites occupy active
enhancers.
ChIP-STARR-Seq Dissects Super-Enhancers into Small
Functional Units
Recently, large linear tracts of chromatin, referred to as ‘‘SEs’’
have been identified that function to regulate lineage-specific
gene expression (Whyte et al., 2013). Compared to traditional
enhancers, SEs have increased binding ofMediator, specific his-284 Cell Stem Cell 23, 276–288, August 2, 2018tone marks and lineage-specific TFs. Whether the full length of
SEs is required for biological activity is a matter of debate (Hay
and Hughes, 2016; Moorthy et al., 2017; Shin et al., 2016). We
used our enhancer catalog to dissect the regulatory potential
of DNA underlying SE regions. SEs were first identified by
H3K27ac enrichment in primed (Figure 7A; Data S1) and naive
(Figure S7A) ESCs. Alignment of ChIP-STARR-seq data to these
SEs showed that the H3K27ac intensity used to define SEs
correlated to RPP levels (Figures 7B, S7B, and S7C), supporting
the notion that SE-likeness is an indicator of enhancer activity.
SEs discovered here overlapped strongly between primed and
naive ESCs (n = 824 SEs shared), containing many of the previ-
ously described H1 ESC SEs (Figures S7D and S7E) (Hnisz et al.,
2013). Detailed examination of the FGFR1 SE indicated strong
RPP signals originating from small regions within the SE (Fig-
ure 7C). To exclude the possibility that this observation was
due to limited coverage in our ChIP-STARR-seq libraries, we
included additional STARR-seq libraries made from BACs
covering the FGFR1 SE and two other SEs providing robust
coverage of the entire SEs plus flanking regions (Figures 7C
and S7F). Luciferase assays confirmed spatially restricted
enhancer activity of DNA in the neighborhood of the central
active region of the FGFR1 SE. Strong activity was confined to
a 596 bp region with other DNA elements from this SE devoid
of enhancer activity (Figure 7D). Homozygous deletion of this re-
gion by CRISPR-Cas9 significantly reduced expression of
FGFR1 and WHSC1L1 compared to wild-type cells, without
affecting expression of other flanking genes (Figures S7G and
S7H). Homozygous deletion of two other parts of this SE did
not affect gene expression of target and flanking genes. This
indicates that the FGFR1 SE is composed of small units with
enhancer activity. To test whether this finding is valid globally,
we examined the relative abundance of active plasmids
(RPP R 138) in SEs compared to ‘‘normal’’ enhancers (NEs).
Most enhancers contained only a small percentage of active plas-
mids within their bounds (Figures 7E and 7F). Although this frac-
tion was slightly higher in SEs than in NEs, it accounted for only a
minority (2.8%) of the genome annotated as SEs. Therefore, only
a small part of the large SEs has enhancer function (Figures 7F
and S7I). Notably, regions within naive SEs or within SEs called
in both primed and naive were more frequently active in both
states (18.1% and 13.2%, respectively) than regions within
primed SEs or outside SEs (Figure 7G). Since only a subspace
of SEs displayed enhancer activity, we investigated the relation-
ship between active components and H3K27ac ChIP-seq peaks
by repeating the SE calling without stitching disjoint peaks (ROSE
stitching distance = 0). However, the fraction of active plasmids
remained unaffected indicating that H3K27ac occupancy alone
cannot identify active SE components (Figure S7J).
DISCUSSION
In this study, we present a large-scale analysis of ESC enhancer
activities. By using ChIP-STARR-seq we assessed the ability of
sequences bound by OCT4, NANOG, or marked by H3K4me1
and H3K27ac to function as enhancers. Our results show that
only a subset of these sequences displayed enhancer activity.
We find that TF binding is linked with enhancer activity, in line
with recent reports (Kwasnieski et al., 2014; Ernst et al., 2016;
Kheradpour et al., 2013), but that no individual TF, histone
mark or combination thereof could unequivocally predict
enhancer activity. Our study identified a previously unrecognized
group of functional enhancers that are active in ESCs but are
associated with generic cell processes. This extended enhancer
module is characterized by reduced binding of pluripotency-
associated TFs and histone marks. This reduced binding might
have placed these regions below the detection threshold in pre-
vious ChIP-seq-based studies that lacked a functional readout.
The use of an episomal-plasmid-based reporter system may
be considered a limitation, as it does not fully recapitulate
endogenous chromatin context (Inoue et al., 2017). It is also
possible that in some cases cloned fragments might be too short
to enable all the TF interactions that mediate enhancer function
at the endogenous locus. However, the generally accepted defi-
nition of an enhancer focuses on the functional capacity of DNAto enhance transcription of a reporter gene in an orientation and
position-independent manner (Banerji et al., 1981). Indeed,
several lines of evidence argue for the broad usefulness of
ChIP-STARR-seq as a high-throughput assay of enhancer func-
tion: (1) ChIP-STARR-seq confirmed the function of known en-
hancers; (2) genes near active enhancers tend to be more highly
expressed; (3) active enhancers are marked by motifs of TF
associated with ESCs; (4) active enhancers are enriched in
genome annotations as enhancer chromatin; and (5) deletion
of active enhancers from endogenous loci decreases expression
of linked target genes, whereas deletion of sequences devoid of
enhancer activity in ChIP-STARR-seq did not affect gene
expression.
Previous studies identified crucial roles for OCT4, NANOG,
and SMAD3, the latter of which are downstream mediators of
TGF-b signaling in the maintenance of ESC pluripotency
(James et al., 2005; Xu et al., 2008). Enhancer activity is en-
riched near these binding peaks, suggesting that these TFs
may act combinatorially to provide enhancer function. Other
studies have shown that heterotypic clusters of different TF
binding sites can increase enhancer activity (Smith et al.,
2013) and that sequences marked by H3K122ac but lacking
H3K27ac can act as transcriptional enhancers (Pradeepa
et al., 2016). It would be of future interest to decipher the indi-
vidual contributions of TFs to these active enhancers. Several
classes of TEs were also enriched at active enhancers, as re-
ported recently (Ernst et al., 2016). TEs are enriched in spe-
cies-specific TF binding sites and have been hypothesized to
shape the enhancer network in ESCs (Glinsky, 2015; Kunarso
et al., 2010). Our data indicate that only a limited number of
TEs contribute to enhancer function and can do so in a cell-
state-dependent manner.
Most enhancers studied to date lie within distal elements or in-
tronic sequences. However, some sequences detected by ChIP-
STARR-seq lie near TSSs (n = 3,283 active enhancers within
500bp of a TSS). As tested enhancers are inserted downstream
of the GFP ORF in STARR-seq (Figure 1A) GFP-positive tran-
scripts cannot be made by initiating transcription in situ from
an inserted TSS. Therefore, sequences near a TSS can exert
enhancer activity, in line with recent reports (Dao et al., 2017; En-
greitz et al., 2016). Furthermore, a subset of extended module
enhancers lies close (±2 kb) to a TSS and display GO enrich-
ments related to housekeeping genes and metabolic processes.
This suggests that nearby enhancers may regulate some human
housekeeping genes. It would be interesting to investigate
links between enhancers and promoters that distinguish house-
keeping genes from developmental genes, as identified in
Drosophila (Zabidi et al., 2015).
Several groups have recently developed culture conditions
supporting a more naive ESC state enabling contribution to
interspecies chimeras (Gafni et al., 2013; Takashima et al.,
2014; Theunissen et al., 2014; Wu et al., 2017). Here, we
have used one such culture condition to compare primed and
naive ESCs and find that enhancer activity is altered substan-
tially. Pluripotency in both states is established by differential
use of regulatory elements that is partly reflected in gene
expression changes. Further studies should clarify differences
between states of pluripotency and how these relate to altered
enhancer usage.Cell Stem Cell 23, 276–288, August 2, 2018 285
SEs are characterized by large domains marked by H3K27ac
with increased binding of Mediator and other TFs. ChIP-
STARR-seq analysis indicates that the majority of sequences
within SEs lack enhancer activity. Rather, enhancer activity is
limited to small domains within the SEs that frequently overlap
with TF binding sites. This suggests that the observed chromatin
signatures at SEs might be a consequence of enhancer activity
frommuch smaller units. Recent reports suggest that SE constit-
uents may function alternatively as independent and additive
enhancers (Hay and Hughes, 2016; Moorthy et al., 2017), as con-
stituents in a temporal and functional enhancer hierarchy (Shin
et al., 2016), or as interdependent units (Hnisz et al., 2015) exhib-
iting synergy (Suzuki et al., 2017). The large-scale identification
of such active constituents within SEs reported here should
help to decipher the regulatory mechanisms contributing to SE
formation and function.
Thecatalogof functionalenhancerspresentedhereprovides the
means to refine models of the regulatory circuitry of ESCs and a
framework for understanding transcriptional regulation in humans.
Given the increasing appreciation of the importance of the regula-
tory genome in health and disease, we expect that this resource
and the more widespread use of MPRAs, such as ChIP-STARR-
seq, should advance basic and translational research.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines
H9 female human ESCs were a gift of David Hay (Edinburgh). All cells were regularly karyotyped and checked for the presence of
mycoplasm.
Cell Culture conditions
H9 human ESCs were cultured on Matrigel coated cell culture plates, using mTesR1 medium (Stem Cell Technology, 05850). Cells
were routinely split (ratio 1:3-1:4) using 0.5mMEDTA (Invitrogen, 15575020). For transfection, single cells were obtained by Accutase
treatment (Invitrogen, A1110501), in the presence of Rock inhibitor, Y-27632 (10uM, Cambridge bioscience, SM02-10). For conver-
sion to the naive state, cells were split on irradiated MEFs on gelatin coated plates and media was changed to NHSM media, as
described by Gafni et al. (2013), containing knockout DMEM (Invitrogen), 20% knockout serum (Invitrogen), human insulin (Sigma,
12.5 mg ml-1 final concentration), 20 ng ml-1 recombinant human LIF (Millipore), 8 ng ml-1 recombinant bFGF (Peprotech) and
1 ng ml-1 recombinant TGF-b1 (Peprotech), 1 mM glutamine (Invitrogen), 1% nonessential amino acids (Invitrogen), 0.1 mM beta-
mercaptoethanol (Invitrogen), penicillin-streptomycin (Invitrogen) and small molecule inhibitors: PD0325901 (1 mM, ERK1/2i, Axon
Medchem); CHIR99021 (3 mM, GSKbi, Axon Medchem); SP600125 (10 mM, JNKi, Abcam ab120065) and SB203580 (10 mM,
p38i,Abcam ab120638) Y-27632 (5 mM, ROCKi) and protein kinase C inhibitor G06983 (5 mM, PKCi, Abcam, ab144414). Cells
were 1:10 passaged using TrypLETM (Invitrogen, 12604021) in the presence of Rock inhibitor and maintained for more than 10 pas-
sages in NHSM media prior to analysis.
METHOD DETAILS
Experimental Design
All experiments were replicated. For the specific number of replicates done see either the figure legends or the specific section below.
No aspect of the study was done blinded. Sample size was not predetermined and no outliers were excluded.
Chromatin immunoprecipitation
For chromatin immunoprecipitation, 2x107 H9 primed or naive ESC were harvested in 9 mL of medium and cross-linked by addition
of 270 mL 37% Formaldehyde (Sigma, final concentration of 1%), for 10 min at room temperature under rotation. 1 mL of 1.25 MCell Stem Cell 23, 276–288.e1–e8, August 2, 2018 e3
Glycine was added, cells were incubated on ice for 5min and 3xwashedwith ice cold PBS. At this point, cross-linked cell pellets were
snap-frozen and stored at80C, or immediately processed for sonication. Prior to sonication, cells were resuspended in 1ml TE-I-
NP40 (10mM TRIS-HCl pH 8, 1mM EDTA, 0.5% NP40, 1mM PMSF, 1x Protease inhibitor complex (PIC, Complete tablets,
04693116001, Roche)) incubated on ice for 5 min and centrifuged for 5 min at 2500 rpm at 4C in a refrigerated bench top centrifuge
(Eppendorf). Supernatant was removed and nuclei were resuspended in 1 mL ice-cold lysis buffer (50mM TRIS-HCl pH 8, 10mM
EDTA, 1% SDS, 1mM PMSF, 1x PIC) and transferred to a 15 mL Falcon tube for sonication, using a Diagenode Bioruptor Next
Gen (40 cycles of 30’’ on, 30’’ off). After transfer to an Eppendorf tube and centrifugation for 10 min at 13200 rpm at 4C, chromatin
solution was aliquoted and used for immunoprecipitation or snap-frozen and stored at80C. A 20 ml sample was taken and served
as a total input control. For immunoprecipitation, Protein Dynabeads G (10004D, Life Technologies) were washed with PBS and incu-
bated for 6 hours with 5 mg of antibody, at 4C on a rotating wheel. Antibodies used were: goat-anti-NANOG (AF1997, R&D Systems),
rabbit-anti-OCT4 (AB19857, Abcam), rabbit-anti-H3K4me1 (AB8895, Abcam) and rabbit-anti-H3K27ac (AB4729, Abcam); as a con-
trol, respective IgG antibodies were used (rabbit-IgG: 10500C, Life Technology, goat-IgG: SC-2028, Santa Cruz Biotechnology). After
washing with PBS, antibody-coupled beads were incubated with 200 mL chromatin solution, diluted to a final volume of 2 mL with
dilution buffer (167mM NaCl, 16.7mM TRIS-HCl pH 8.1, 1.2mM EDTA, 0.01% SDS, 1.1% Triton X-100, 1mM PMSF, 1x PIC), over-
night at 4C on a rotating wheel. Washing of beads was performed by incubation with ice-cold 1 mL of washing buffer, for 5 min, at
4C on a rotating wheel, followed by removal of supernatant using a magnetic stand, for each of the following: 2x with wash buffer 1
(10mM TRIS-HCl pH 7.6, 1mM EDTA, 0.1% SDS, 1% Triton X-100, 0.1% NaDeoxychloate), 2x with wash buffer 2 (10mM TRIS-HCl
pH 7.6, 1mM EDTA, 0.1% SDS, 1% Triton X-100, 0.1% NaDeoxychloate, 150mM NaCl), 2x with wash buffer 3 (250mM LiCl, 0.5%
NP40, 0.1%NaDeoxychloate), 1x with TE 1x with 0.2% Triton X-100 and 1x with TE 1x, after which beads were resuspended in 100ul
TE1x. Immunoprecipitated chromatin and total input control were decross-linked, by addition of 3 mL of 10% SDS and 5 mL Protein-
ase K (20 mg/ml, Roche) and 10 mL RNase A (50 mg/ml, Roche) to each tube and incubation overnight at 65Con a shaking thermomixer
block, 1400 rpm (Eppendorf). The next day, beads were briefly vortexed and supernatants were transferred to new tubes using the
magnetic stand. 100 mL of TE1x containing 500mM NaCl was added to the beads and briefly vortexed, after which the supernatant
was added to the first fraction of collected supernatant. Following Phenol / chloroform extraction, DNA was precipitated using 1 mL
glycogen (20mg/ml), 1/10 vol NaOAc (3M) and 100% ice-cold Ethanol, at 20C for 1 hour, followed by centrifugation at 13200 rpm
for 1 hour at 4C. After a final wash with 70% ethanol, the DNA pellet was dried and resuspended in 50 mL H2O. Concentration of ChIP
DNA was determined by Qubit measurement following manufacturer’s instructions and sonication was assessed by gel-electropho-
resis of total input DNA (target fragment size between 200 and 600 bp).
ChIP-qPCR
Concentration of ChIP and total input control DNA was assessed by Qubit measurement (LifeTech) according to manufacturer’s in-
structions and was diluted to 2 ng/ml. 2 mL of DNA was used per qPCR reaction, using a 2x Takyon qPCRmaster mix (No ROX SYBR,
UF-NSMT-B0701, Takyon). qPCR reactions were run on a Roche Lightcycler 480 II (Roche), using the following cycle conditions:
95C 3 min, (95C 10 s, 60C 30 s, 72C 25 s) x45, followed by a melting curve from 95 to 65C. All data shown are averages of
at least 2 biological replicates and 3 technical replicates. All primers used are shown in Table S5.
ChIP-seq, ChIP-STARR-seq plasmid library preparation
For ChIP-seq and ChIP-STARR-seq plasmid library generation, 10 ng of ChIP DNA was used as starting material. Using NEB Next
ChIP-seq library preparation kit (E6200 or E6240, NEB), DNA was end-repaired, dA-tailed and adaptor-ligated according to manu-
facturer’s instructions. After adaptor ligation and purification using AMPure-XP beads (0.8x, Beckman Coulter) and elution into 30 mL
of 0.1xTE, 25 mL of the reaction product was used for ChIP-seq library preparation, by PCR amplification with Illumina index primers
(7335 and 7500, NEB) using the NEBNext QHot start high fidelity master mix (M0543S, NEB) according tomanufactures instructions
(cycle conditions: 98C 30 s, (98C 10 s, 65C 75 s) x15, 65C 5 min, 4C hold). After an additional round of AMPureXP bead puri-
fication, DNA was eluted in 0.1xTE without further size selection. Quality and quantity of the prepared ChIP-seq libraries was as-
sessed on an Agilent Tapestation. All sequencing occurred on an Illumina HiSeq 2500 platform, using 50bp single-end sequencing.
The remaining 5 mL of purified adaptor ligated DNAwere used for ChIP-STARR-seq plasmid library generation. Therefore, DNAwas
diluted to a total volume of 10 mL in 0.1xTE and used as an input in 83 50 mL PCR reactions using Phusion Polymerase, High-fidelity
buffer (M0530L, NEB) and primers 147 STARRseq libr FW (TAGAGCATGCACCGGACACTCTTTCCCTACACGACGCTCTTCC
GATCT) and 148 STARRseq libr RV (GGCCGAATTCGTCGAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT) (Arnold et al.,
2013), which prime on the adaptor sequences and add a 50and 30 15 nucleotide homology sequence to the reaction products which
are used for Gibson assembly. After PCR amplification (cycle conditions: 98 2min, (98C10 s, 62C30 s, 72C30 s) x 15, 72C5min,
4C hold), PCR reactions were pooled, purified using AMPure XP beads (1.8x), eluted in 30 mL 0.1xTE and used for Gibson assembly.
Therefore, 15 mg of the mammalian STARRseq plasmid (a kind gift of A.Stark) (Arnold et al., 2013) were digested with AgeI-HF and
SalI-HF (NEB) for 8h at 37C, column purified (Nucleospin purification columns, 740609250, Machery-Nagel), eluted in 30 ml elution
buffer and used as a vector in a Gibson reaction, using 2 mL of digested plasmid, 5 mL purified PCR product, 3 mL H20 and 10 mL of a
home-made Gibson reaction (100mM Tris-HCl, 10mMMgCl2, 0.2 mM dNTP (each), 0.5U Phusion DNA polymerase (NEB), 0.16U 50
T5 exonuclease (Epicenter), 2 Gibson reactions per library. After incubation at 50C for 1 hour, Gibson reaction were pooled and
precipitated by addition of 1 mL Glycogen (20 mg/ml, Roche, 1090139300), 5 mL NaOAc (3M) and 125 mL ice-cold 100% ethanol, in-
cubation at 20C for 1 hour and centrifugation for 1 hour at 13200 rpm at 4C, followed by a final wash in 70% ethanol. After aire4 Cell Stem Cell 23, 276–288.e1–e8, August 2, 2018
drying, DNA pellet was dissolved in 10 mL water and used for electroporation into electrocompetent MegaX DH10b E.coli bacteria
(Invitrogen), according to manufacturer’s instructions, using a Biorad pulser. A total of 5 electroporations per library were performed
with each 2 mL of DNA. After recovery in 1 mL SOCSmedium each, bacteria were grown for 1 hour at 37C in a bacterial shaker in the
absence of antibiotics. Then, bacteria were pooled together and 50 mL of a 1:100 and 1:10000 dilution was plated on Ampicillin con-
taining Agar plates to enable estimation of the number of transformants after overnight growth at 37C (Control electroporations with
Mock-Gibson without addition of PCR product plated on Ampicillin, or digested STARRseq plasmid transformations on Ampicillin-
and Ampicillin/Chloramphenicol-containing Agar plates were negative, confirming complete digestion of the STARR-seq plasmid
and a functional Ccdb counter-selection in DH10bE.Coli). The remaining 5 mL of bacteria culture were incubated in a total volume
of 2 l of LB-media supplemented with Ampicillin and allowed to grow for 16 hours in a bacterial shaker at 37C. Plasmid DNA was
isolated using a QIAGEN Maxiprep kit according to manufacturer’s instructions and eluted in 500 mL 10mM Tris-HCl, pH 7.4. Con-
centration was determined by Nanodrop measurement. For BAC-STARR-seq of super enhancer regions, three BAC clones (RP11-
357D8, RP11-100L8, RP11-713N22) were ordered at the BAC PAC resource center from CHORI. DNA was isolated according to
standard procedures, mixed in equimolar quantities and subjected to sonication, after which 10 ng was used for end-repair, adaptor
ligation and cloning of plasmid libraries as described above for the ChIP-STARR-seq.
Transfection of plasmid libraries
Primed and naive H9 ESCs were transfected using either Nucleofection (Lonza, VPH-5022), or using Lipofectamine 3000 according
to manufacturer’s instructions. For each transfection, 6-10 million cells were used (approximately 2.5-4.2 x108 cells in total) and
transfected with 8 mg of plasmid library DNA and 500 ng pmCherry-N1 plasmid (Clonetech) as transfection control. Cells were incu-
bated in 10 cm dishes and 24h post-transfection, single cells were harvested and subjected to FACS. Non-transfected cells were
used to set sorting gates, DAPI was used as a marker for dead cells. All percentages mentioned are relative to the fraction of
DAPI-negative, single cells.
ChIP-STARR-seq RNA and DNA samples
A minimum of 400,000 GFP-positive, sorted cells were used to isolate total RNA using Trizol (Thermo Fisher) according to manufac-
turer’s instructions. On average, 2million GFP-positive cells were used per sample. ThemRNA fraction was captured usingOligo (dT)
25 beads (61002, Life Technologies) and DNaseI treated (18068-015, Life Technologies), followed by reverse transcription using 2 mL
SuperscriptIII (18080-044, Life Technologies) using a GFP-mRNA specific primer (149 STARRseq rep RNA cDNA synth, CAAACT
CATCAATGTATCTTATCATG) at 50C for 90 minutes, in a total reaction volume of 21 ml. To repress residual plasmid DNA contam-
ination, cDNA was PCR amplified using a combination of primers (152 STARR reporter specific primer 2 fw, GGGCC
AGCTGTTGGGGTG*T*C*C*A*C and 153 STARR reporter specific primer 2 rv, CTTATCATGTCTGCTCGA*A*G*C, where * represent
phosphorothioate bonds) spanning a synthetic intron in the STARR-seq plasmid, as previously described (Arnold et al., 2013). PCR
was performed with Phusion polymerase and High-fidelity buffer, in 6 3 50 ml reactions (cycling conditions: 98C 2 min, (98C 10 s,
62C 30 s, 72C 70 s) x15, 72C 5 min, 4C hold). PCR reactions were pooled, purified using AMPureXP beads (1.0x) and eluted in
18 mL 0.1xTE. Absence of significant plasmid contamination in the PCR amplified cDNA was assessed by qPCR using a primer-set
amplifying an amplicon from the STARR-seq plasmid backbone (161 STARRseq detect plasmid backbone qPCR fw, CATCATCGG
GAATCGTTCTT, and 162 STARRSeq detect plasmid backbone qPCR rv, TGAAGATCAACTGGGTGCAA), relative to a primer-set
amplifying GFP (154 STARRseq GFP fw, ACGGCCACAAGTTCTCTGTC, and 155 STARRseq GFP rv, GCAGTTTGCCAGTAGTG
CAG). PCR amplified cDNA was then used in a second round of PCR to add Illumina index primers (7335, 7500, NEB) using priming
on the adaptor sequences added during the plasmid library generation. PCR was performed in 1-4x 50 mL reactions using Phusion
polymerase and High-fidelity buffer (NEB)(cycling conditions: 98C 2 min, (98C 10 s, 65C 30 s, 72C 30 s) x13, 72C 5 min, 4C
hold), after which PCR reactions were pooled, purified using AMPureXP beads (1.0x) and eluted in 15 mL 0.1xTE. Corresponding
plasmid libraries were similarly amplified in a nested PCR, using primers detecting the STARR-seq plasmid (160 STARR reporter spe-
cific primer for plasmid DNA fw, GGGCCAGCTGTTGGGGTG, and 153 STARR reporter specific primer 2 rv, CTTATCATGTCTGCTC
GA*A*G*C, where * represent phosphorothioate bonds) and Illumina index primers. In addition to sequencing libraries prepared from
plasmid maxiprep DNA, we also sequenced plasmid libraries reisolated from transfected ESCs. For this, we transfected H9 ESCs as
described above and harvested non-sorted cells 24h post-transfection, followed by plasmid reisolation using a QIAGEN miniprep
isolation kit and sequencing library preparation. Quantity and quality of generated sequencing libraries was assessed on an Agilent
Tapestation. All sequencing occurred on an Illumina HiSeq 2500 platform, using 50bp or 125 bp paired-end sequencing. Up to 22
RNA samples were pooled on a single lane. During data-processing all reads were trimmed to 50bp length to improve consistency.
RT-qPCR
For RNA analysis of complete cultures, cells were lysed in Trizol (Thermo Fisher) and RNAwas prepared according tomanufacturer’s
instructions. 1 mg of RNA was treated with DNaseI (Invitrogen) to remove genomic DNA contamination and cDNA was obtained
through reverse transcription using SuperScriptIII (Invitrogen) in the presence of RNaseOUT (Invitrogen). cDNA was diluted in
DEPC-treated water to a final volume of 200 mL and 2 mL of cDNA was used per qPCR reaction, using a 2x Takyon qPCR master
mix (No ROX SYBR, UF-NSMT-B0701, Takyon). qPCR reactions were run on a Roche Lightcycler 480 II (Roche), using the following
cycle conditions: 95C 3 min, (95C 10 s, 60C 30 s, 72C 25 s) x45, followed by a melting curve from 95 to 65C. All data shown are
averages of at least 2 biological replicates and 3 technical replicates, normalized to TBP. All primers used are shown in Table S5.Cell Stem Cell 23, 276–288.e1–e8, August 2, 2018 e5
Immunostaining
Cells were grown on culture dishes suitable for confocal microscopy (Ibidi, 81156) and fixed using 4% v/v Paraformaldehyde at room
temperature for 10 min. After permeabilisation using 0.3% Triton/PBS and incubation with blocking solution (1% BSA, 3% Donkey
serum, 0.1% triton in PBS), cells were incubated with primary antibodyO/N at 4C. After washing with PBS, cells were incubated with
secondary antibody at RT for 1h, washed and counterstained with DAPI. Imaging occurred on a Leica SP8 STED-CW confocal mi-
croscope and images were processed using ImageJ software. Antibodies used are: goat-anti-NANOG (1: 200, AF1997, R&D Sys-
tems), rabbit-anti-OCT4 (1: 200, AB19857, Abcam). Secondary antibodies were Donkey-anti-goat conjugated to Alexa fluor488
(1:800, A11055, Invitrogen) and Donkey-anti-rabbit conjugated to Alexa fluor568 (1:1000, A10042, Invitrogen).
Western blotting
Whole cell protein extracts were isolated and western blotting was performed using standard procedures using pre-cast 10% Bis-
Tris Bolt gels (Invitrogen). Primary antibody used was goat-anti-NANOG (1: 500, 1 mg/ml, AF1997, R&D Systems), secondary anti-
body conjugated to fluorophores was donkey-anti-goat-IRDey680 (1:500, 926-68074, Li-Cor). Rabbit-anti-Laminin B (1:1000,
AB16048, Abcam) served as a loading control and was detected by chemi-iluminescence. Imaging occurred on an Odyssey imager
(Li-Cor).
Luciferase assays
Enhancer sequences were PCR amplified from human genomic DNA using Phusion polymerase and cloned byGibson assembly into
a KpnI-NheI linearized Pgl3 promoter luciferase vector. For primer sequences, see Table S5. All constructs were sequence-verified
by Sanger sequencing and co-transfected with a Renilla expressing plasmid using Lipofectamin 3000 into H9 ESCs. 48h post-trans-
fection illuminescence was assessed using the Dual Glo luciferase kit (E2920, Promega) according tomanufacturer’s instructions, on
a Promega Glumax Multidection system. All data shown are average from at least two biological replicates and two technical rep-
licates, representing fold-change in luciferase activity compared to empty vector controls and normalized for Renilla transfection
control.
Alternative promoter STARR-seq constructs
To replace the SCP1 minimal promoter from the original STARR-seq plasmid (Arnold et al., 2013), the plasmid was linearized by re-
striction digestion using KpnI-ApaI (NEB) and used to ligate annealed oligonucleotides, coding for the adenovirus major late (AML) or
CMV IE core promoter (Juven-Gershon et al., 2006). Test enhancer sequences were introduced by PCR amplification and Gibson
assembly as done during library cloning. All constructs were verified by Sanger sequencing. Oligonucleotide sequences are
given in Table S5. Constructs (1 mg of each plasmid) were transfected in H9 primed ESCs cultured in 6-well plates using Lipofect-
amine 3000 and fluorescents was assessed using flow cytometry. Shown are the results for two independent experiments
(analyzing > 30.000 GFP positive cells each), comparing all identical tested enhancer sequences in constructs with the SCP1,
AML or CMV minimal promoter transfected in parallel.
CRISPR/Cas9 genome editing
Oligonucleotides for gRNAs (Table S5) flanking the tested enhancers were annealed and cloned into a BbsI digested spCas9
plasmid, from which the gRNAs are separately expressed together with a eSpCas9(1.1)-t2a-mCherry or eSpCas9(1.1)-t2a-GFP
(modified from Addgene plasmid #71814) (Slaymaker et al., 2016). All plasmids were sequence verified and 1 mg of each gRNA
was used to transfect primed H9 ESCs in a 6-well plate using Lipofectamine 3000. 48h post-transfection, mCherry and GFP double
positive cells were FACS sorted and cells were plated at low density in 10 cm dishes coated with Matrigel in conventional mTesR1
ESC medium. Emerging clones were expanded and genotyped by PCR using primers flanking the gRNA targets (Table S5). For the
pos3_ID1 enhancer, a nested PCR using outer and inner primers was performed. All candidate clones were validated by Sanger
sequencing of PCR products and correct clones were expanded.
QUANTIFICATION AND STATISTICAL ANALYSIS
ChIP-seq and ChIP-STARR-seq data processing
We trimmed possible adaptor contaminants from reads using Skewer (Jiang et al., 2014). Trimmed reads were then aligned to the
GRCh37/hg19 assembly of the human genome using Bowtie2 (Langmead and Salzberg, 2012) with the ‘‘–very-sensitive’’ parameter.
Genome browser tracks were created from all aligned reads with the genomeCoverageBed command in BEDTools (Quinlan and Hall,
2010) and normalized such that each value represents the read count per base pair per million uniquely mapped reads. Finally, the
UCSC Genome Browser’s bedGraphToBigWig tool was used to produce a bigWig file.
ChIP-STARR-seq enhancer activity levels
For ChIP-seq and plasmid DNA-seq libraries, peak calling was performed with MACS2 version 2.1.0.20150420 (Zhang et al., 2008)
with default parameters (narrow peak calling, fragment length detection from libraries, genome size 2.7x109 bp, FDR < 0.05), using
the respective input samples as background. Significant peaks (FDR < 0.05) were fixed to a width of 500 bp from the peak summit fore6 Cell Stem Cell 23, 276–288.e1–e8, August 2, 2018
transcription factors and 1000 bp for histone modifications. Peaks overlapping blacklisted features as defined by the ENCODE proj-
ect (Hoffman et al., 2013) were removed. ChIP-seq peaks are given in Data S1.
To define a non-redundant set of enhancers to compare in our analysis of ChIP-seq, plasmid DNA-seq and ChIP-STARR RNA-seq
samples, we produced a set of regions by merging all peaks across cell types and experiment types (ChIP-seq and plasmid DNA-
seq). This operation results in regions that can be very large. To preserve high genomic resolution for our analysis, large regions were
split in half recursively until all regions were at most 1000 bp long. All further analysis were performed on these scaffold regions.
We initially quantified the intensity of ChIP-seq, plasmid DNA-seq and ChIP-STARR RNA-seq datasets in the enhancer peak re-
gions by counting the number of aligned fragments (only properly paired, concordantly aligning and uniquely mapping fragments –
i.e., bothmate readsmapped to same chromosomewithMAPQ> = 30 – were kept) overlapping each enhancer region. To get amore
accurate and precise measure of plasmid reporter intensity for further analysis, we thenmade use of our paired-end sequencing data
to unequivocally link RNA-seq reads to the plasmid that they came from. To do so, wematched RNA-seq reads to plasmid reads with
the exact same start coordinate of the first read and the exact same end coordinate of the second read. Comparing the counts for
both made it possible to define a measure of RNA-seq activity relative to the abundance of plasmids in the. To avoid distortion by
differences in sequencing depth, we normalized the raw read counts for each plasmid library and all RNA-seq datasets derived
from transfections of this library together using DESeq2 (Love et al., 2014). The ratio of normalized RNA-seq and (plasmid) DNA-
seq reads was used as a measure of enhancer activity (reads per plasmid, RPP). We then calculated the mean RPP of replicate
measurements for the same plasmid position and used the maximum observed RPP value per region as an estimate of enhancer-
peak-level activity. Since our individual replicate datasets were sparse, with the same plasmids infrequently measured in both
replicates, but our overall coverage of enhancers was much better, we used RPP from all datasets generated in the same cell
type (so specific to either primed or naive H9 ESCs) for this purpose. We could do so because the ChIP-STARR-seq plasmid libraries
are independent from the antibody target used to pull down the enriched DNA fragments, thus the plasmids in all libraries jointly
report the activity of the same genome. To objectively define a threshold for discriminating highly active and inactive genome regions,
we looked at the curve of RPP ranks versus RPP values (Figure 2C) and defined points of change in themean and variation of the data
using the changepoint package in R (Killick, 2014). The highest value was used as a threshold for active enhancers (q = 138). The
coordinates of all genome regions assessed with activity calls are given in Table S2 and Data S1.
Motif enrichment analysis for ChIP-seq data
For de novomotif discovery (Figure S5), BED files of ChIP-seq datasets were generated with 500 bp sequences centered on the nar-
row ChIP-seq peak, and used for motif enrichment analysis using CentriMo (http://meme-suite.org/) (Bailey and Machanick, 2012),
using default settings.
Assignment of enhancers to genes
We used GREAT, version 3.0.0 (McLean et al., 2010) to assign regulatory elements identified in ChIP-STARR-seq to their putative
target genes, using the following settings: basal plus extension, proximal 5kb upstream and 1kb downstream, plus distal up to
100kb. Publically available, processed RNA-seq data from primed human ESCs were downloaded (Gifford et al., 2013; Ji et al.,
2016; Takashima et al., 2014) and their RPKM value distribution was plotted for the various ChIP-STARR-seq regions grouped by
activity in RPP. For naive ESCs, we used publically available microarray data from the original study describing gene expression
in naive cells cultured under NHSM conditions (Gafni et al., 2013).
Comparison to previously published enhancers
The coordinates of putative enhancers were obtained from the supplemental data of Hawkins et al. (2011), Rada-Iglesias et al.
(2011), and Xie et al. (2013), and when necessary converted to the hg19 version of the human genome using the liftOver tool. Over-
lapping enhancers were merged into 76,666 putative enhancers and joint to our ChIP-STARR-seq enhancers using
GenomicRanges (Lawrence et al., 2013) in R (see Figure S4A; Table S2). We refer to those enhancers that overlapped with pre-
viously published enhancers and showed a ChIP-STARR-seq activity of RPP > = 138 as the core enhancer module (n = 7,948).
Conversely, we refer to active enhancers (RPP > = 138) that did not overlap with the previously published enhancers as the
extended enhancer module (n = 24,405).
Functional enrichment analysis
To help understand the function and relevance of different groups of enhancers, we used three types of functional enrichment anal-
ysis (Table S3).
(a) We used LOLA (Sheffield and Bock, 2016) to determine the relative over-representation of ChIP-seq peaks related transcrip-
tion factor binding and other elements of known regulatory function. To this end, we used the codex, encode_tfbs, and enco-
de_segmentation databases contained in the LOLACore database and tested for the enrichment of overlap in genome regions
with a specific level of activity (high, low or inactive) over the background of all ChIP-STARR-seq peaks.
(b) We also used the Enrichr API (January 2018 version) (Chen et al., 2013) to test genes linked to enhancers of interest for sig-
nificant enrichment in numerous functional categories. To comply with the web interface, we considered the 1000 genes
closest to the tested peaks for enrichments. In all plots, we report the ‘‘combined score’’ calculated by Enrichr, which is aCell Stem Cell 23, 276–288.e1–e8, August 2, 2018 e7
e8product of the significance estimate and the magnitude of enrichment (combined score c = log(p) * z, where p is the Fisher’s
exact test p value and z is the z-score deviation from the expected rank).
(c) We additionally used the GREAT web interface (version 3.0.0) (http://great.stanford.edu/public/html/) (McLean et al., 2010) for
gene ontology analysis, using the following settings: basal plus extension, proximal 5kb upstream and 1kb downstream, plus
distal up to 100kb, including curated regulatory domains, and whole genome (hg19) as background.Machine learning
We used the random forest classifier implementation in the h2o R package (https://github.com/h2oai/h2o-3) to train models for pre-
dicting enhancer activity (‘‘Active’’ versus ‘‘Inactive’’) in primed and naive ESCs and to discriminate enhancers from the Core and
Extended module (‘‘Core’’ versus ‘‘Extended’’). Three types of features based on the DNA underlying each ChIP-STARR-seq region
were used as inputs: (a) sequence conservation. The maximum PhastCons score from overlaps with the UCSC Golden Path refer-
ence was used per region; (b) GC content calculated from alphabet frequency in R; (c) dinucleotide frequencies calculated with the
bioconductor package Biostrings), taking the maximum on either forward or reverse strand; and (d) occurrence of knownmotifs from
the HOCOMOCO database (Kulakovskiy et al., 2016) (v11; limited to ‘‘excellent’’ [A] and ‘‘good’’ [B] quality motifs). The tool FIMO
(v4.10.2) (Grant et al., 2011) was used (parameters: –no-qvalue–text–bgfile motif-fil) to scan DNA sequences for these motifs and re-
gions with at least one hit (p < 0.05) were counted. Each classifier was trained on balanced classes from the complete set of ChIP-
STARR-seq regions (excluding missing RPP values) or on all active enhancers (RPP > = 138; for Core/Extended discrimination) using
10-fold cross-validation and evaluation 500 trees with 50 features sampled at each split and a maximum depth of 10 (parameters:
mtries = 50, nfolds = 10, keep_cross_validation_predictions = T, balance_classes = T, ntrees = 500, max_depth = 10).
Enrichment analysis for transposable elements
The UCSCRepeatMask (hg19) was downloaded from the UCSC Table Browser, imported into Galaxy (https://usegalaxy.org/) (Afgan
et al., 2016) and joined to the ChIP-STARR-seq activity calls for primed or naive ESCs. The number of overlaps of each type of repeat
(noverlaps) with all ChIP-STARR-seq regions (n) was used to calculate the relative frequency (fall = noverlaps/n). Multiplication of the rela-
tive frequency with the number of regions (ntest, e.g., nactive,primed) in any tested groups yields the expected frequency (E). This number
was compared with the actual observed frequency in the subgroups (ftest = noverlap,test/ntest = O) to calculated the observed versus
expected ratio (O/E). We considered repeats with O/E < 0.5 as depleted, or O/E > 2 as enriched. For the subsequent data interpre-
tation we only focused on transposable elements that were present multiple times (noverlap > 15) in all ChIP-STARR-seq regions.
Super-enhancer analysis
To call super-enhancers in primed and naive H9 ESCs, we used the ROSE software (v0.1) (Whyte et al., 2013) to combine (‘‘stitch’’)
H3K27ac ChIP-seq peaks within 12.5 kb of each other and excluding 2.5 kb around known transcription start sites. An alternate
analysis was also run with stitching distance d = 0 for comparison. We then asked the software to quantify the ratio of the
H3K27ac ChIP-seq signal in primed and naive ESCs over the total input control and to call super-enhancers. The coordinates of
all stitched enhancers, as well as primed and naive super-enhancers are given in Data S1.
Statistics for qPCR and luciferase assays
qPCR and luciferase assay figures were plotted and statistics were calculated using GraphPad Prism 5 software, p < 0.05 was
considered significant. Statistical tests used are indicated in the figure legends. For the qPCR analysis of CRISPR deleted enhancer
clones in Figure 2E, we calculated expression as follows: in each graph (with the exception of TBX3), average results for the indicated
enhancer deletion (heterozygous (+/) or homozygous (/) as indicated) are plotted relative towild-type, n = number of cell lines per
genotype. Wild-type controls consisted of H9 parental, two untransfected H9 clones and all remaining clones that were wild-type for
the respective allele. Genes assessed were the presumed target gene and four randomly selected genes. For the TBX3 intronic dele-
tion, three H9wt and three/ deletion clones were assessed for three amplicons detecting TBX3mRNA and two flanking genes. All
measurements occurred at two different passages, in two independent cultures measured in duplicate.
DATA AND SOFTWARE AVAILABILITY
Data availability
High-throughput sequencing data generated in this study have been submitted to the Gene Expression Omnibus (GEO): accession
code GEO: GSE99631, to the Sequence Read Archive (SRA): accession codes SRA: SRP108517, SRA: SRP108518, SRA:
SRP108519, and SRA: SRP108520. A BioProject for this study has also been registered: PRJNA389108.
ADDITIONAL RESOURCES
Additional data, an interactive search tool for active enhancers in the proximity of genes and the genome browser track hub providing
raw and processed ChIP-STARR-seq data for interactive visualization and processing with online tools such as Galaxy, are available
from a supplemental website under the following URL: http://hesc-enhancers.computational-epigenetics.org.Cell Stem Cell 23, 276–288.e1–e8, August 2, 2018
